Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
TPO MIMETIC FUSION PROTEINS AND METHODS OF USE SUBMISSION OF SEQUENCE LISTING AS ASCII TEXT FILE
Document Type and Number:
WIPO Patent Application WO/2023/044774
Kind Code:
A1
Abstract:
Provided are recombinant peptides comprising a recombinant human p75 TNF receptor and TPO mimetic peptides linked by an Fc fragment of IgG1. The recombinant peptides can form a homodimer by inter-chain disulfide bond in the Fc region and can have six TPOR binding and/or activating domain in the C-terminus. The recombinant peptides provided herein are useful for increasing platelet count, e.g., for treating thrombocytopenia. Also provided herein are methods for producing the recombinant peptides, formulations and therapeutic methods.

Inventors:
LIANG PENG (CN)
Application Number:
PCT/CN2021/120388
Publication Date:
March 30, 2023
Filing Date:
September 24, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SICHUAN CLOVER BIOPHARMACEUTICALS INC (CN)
International Classes:
C07K19/00; A61K38/16; A61P7/04; C12N15/62; C12N15/64; C12N15/86
Domestic Patent References:
WO2003024384A22003-03-27
Foreign References:
CN101103045A2008-01-09
CN112494658A2021-03-16
CN102382850A2012-03-21
CN1325447A2001-12-05
Attorney, Agent or Firm:
MERITS & TREE (CN)
Download PDF: